Novel biomarkers for the identification and targeted therapy of gastric cancer

被引:10
作者
Liu, Lei [1 ,2 ]
Cao, Lei [1 ,2 ]
Gong, Biao [3 ]
Yu, Jun [1 ,2 ]
机构
[1] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol,Digest Endoscopy Ctr, Shanghai 200030, Peoples R China
关键词
biomarker; gastric cancer; lncRNA; miRNA; promoter methylation; targeted therapy; FREQUENT EPIGENETIC INACTIVATION; PROMOTER HYPERMETHYLATION; TUMOR-SUPPRESSOR; 1ST-LINE THERAPY; GENE PROMOTER; UP-REGULATION; METHYLATION; COMBINATION; MICRORNAS; SERUM;
D O I
10.1586/17474124.2015.1072466
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastric cancer development follows the pathologic pattern such that chronic inflammation in the gastric mucosa progressively transforms normal mucosa into atrophy, intestinal metaplasia, adenoma/dysplasia and eventually invasive and metastatic tumors. The accumulation of multiple genetic and epigenetic alterations leads to the dysregulation of oncogenes and tumor suppressors, which was considered as the driver behind events during the tumorigenesis. Almost all gastric cancers are adenocarcinomas, which share considerable heterogeneity with distinct morphology, pathogenesis and clinical behavior. Therefore, identifying subtypes of gastric cancers with molecular and genetic features will be beneficial for the early identification and selection of new effective agents for targeted treatment. High-throughput sequencing techniques such as whole genomic, epigenome and transcriptome sequencing and proteomics platforms have identified major genomic characteristics that exhibit identification and prognostic impacts and distinct response patterns. In this article, the authors aim to summarize the information regarding the most promising molecules that may have clinical application as non-invasive biomarkers and therapy targets.
引用
收藏
页码:1217 / 1226
页数:10
相关论文
共 50 条
  • [41] Novel therapy for advanced gastric cancer
    Yue Zhang
    Shenhong Wu
    World Journal of Gastrointestinal Oncology, 2015, (11) : 263 - 270
  • [42] Novel therapy for advanced gastric cancer
    Zhang, Yue
    Wu, Shenhong
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (11) : 263 - 270
  • [43] Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
    Wang, Guocheng
    Huang, Yan
    Zhou, Liang
    Yang, Haojun
    Lin, Huang
    Zhou, Shengfang
    Tan, Zhengang
    Qian, Jun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 198
  • [44] Targeted therapy for advanced gastric cancer: A review of current status and future prospects
    Kanat, Ozkan
    O'Neil, Bert
    Shahda, Safi
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (12) : 401 - 410
  • [45] Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics
    Verma, Henu Kumar
    Ratre, Yashwant Kumar
    Mazzone, Pellegrino
    Laurino, Simona
    Bhaskar, L. V. K. S.
    ALEXANDRIA JOURNAL OF MEDICINE, 2020, 56 (01) : 81 - 92
  • [46] Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer
    Hui Cai
    Yuan Yuan
    Yun-Fei Hao
    Tian-Kang Guo
    Xue Wei
    Ying-Mei Zhang
    Medical Oncology, 2013, 30
  • [47] Plasma metabolomics-based identification of novel biomarkers in early gastric cancer
    Wang, Feng
    Pang, Ruifang
    Yin, Yuxin
    Rong, Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 29 - 29
  • [48] Plasma proteomics-based identification of novel biomarkers in early gastric cancer
    Zhou, Bin
    Zhou, Zhe
    Chen, Yuling
    Deng, Haiteng
    Cai, Yunlong
    Rao, Xiaolong
    Yin, Yuxin
    Rong, Long
    CLINICAL BIOCHEMISTRY, 2020, 76 : 5 - 10
  • [49] The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer
    Liu, Long
    Yan, Bing
    Huang, Junlong
    Gu, Qunhao
    Wang, Lina
    Fang, Meng
    Jiao, Jianpeng
    Yue, Xiaoqiang
    PLOS ONE, 2013, 8 (10):
  • [50] Plasma metabolomics-based identification of novel biomarkers in early gastric cancer
    Wang, Feng
    Pang, Ruifang
    Yin, Yuxin
    Rong, Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 29 - 29